Find Information on a:
| Specific Medicine or Treatment |
| Type of Medicine or Treatment |
| Condition or Medical Procedure |
| Lab Test Procedure |
| Management Issue |
View all Postings for:
| Health Care Providers |
| Patients & Caregivers |
Search ClotCare
Loading
sanofi-aventis, U.S., LLC is a premier sponsor of ClotCare.org. Click here to make a tax-deductible donation and for a full list of sponsors. ClotCare is a 501(c)(3) non-profit organization.
|
|
This site complies with the HONcode standard for trustworthy health information: verify here. |
Prasugrel (New Antiplatelet Agent) Approved in Europe
Marie B. Walker
February, 2009
While controversy has surrounded the FDA Panel's review of Prasugrel in the US, the drug has been approved by the European Commission. Prasugrel will be marketed as Efient in Europe.
Click here to read more about this decision on theheart.org.
Terms, Conditions, & Privacy | Image Copyright Information
Send comments to webmaster@clotcare.org.
ClotCare is a charitable 501(c)(3) non-profit organization. Click here to donate.